Rationale and design of AVERROES: apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment.
Authors : Eikelboom John W JW; O'Donnell Martin M; Yusuf Salim S; Diaz Rafael R; Flaker Greg G; Hart Robert R; Hohnloser Stefan S; Joyner Campbell C; Lawrence Jack J; Pais Prem P; Pogue Janice J; Synhorst David D; Connolly Stuart J SJ;
Affiliations : Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada L8L 2X2. eikelbj@mcmaster.ca
Journal : Am. Heart J. (2010)
Related Links: Pubmed | Publisher website
Apixaban in Patients with Atrial Fibrillation
Authors : Connolly SJ; Eikelboom J; Joyner C; Diener HC; Hart R; Golitsyn S; Flaker G; Avezum A; Hohnloser SH; Diaz R; Talajic M; Zhu J; Pais P; Budaj A; Parkhomenko A; Jansky P; Commerford P; Tan RS; Sim KH; Lewis BS; Van Mieghem W; Lip GY; Kim JH; Lanas-Zanetti F; Gonzalez-Hermosillo A; Dans AL; Munawar M; O'Donnell M; Lawrence J; Lewis G; Afzal R; Yusuf S;
Affiliations : Population Health Research Institute, McMaster University and Hamilton Health Sciences, Hamilton, ON, Canada. stuart.connolly@phri.ca
Journal : The New England Journal of medicine (2011)
Related Links: Pubmed | Publisher website
Display Ads on JAFIB to reach Users world wide...
Suggest an Event to get good mileage from Users World wide...